Comprehensive Stock Analysis of Abbott Laboratories(NYSE:ABT): Raytheon Company(NYSE:RTN)

0
4

Abbott Laboratories (ABT) will report its next earnings on Jan 23 BMO. The company reported the earnings of $0.81/Share in the last quarter where the estimated EPS by analysts was $0.81/share. The difference between the expected and actual EPS was $0/share, which represents an Earnings surprise of 0%.

Many analysts are providing their Estimated Earnings analysis for Abbott Laboratories and for the current quarter 21 analysts have projected that the stock could give an Average Earnings estimate of $0.61/share. These analysts have also projected a Low Estimate of $0.6/share and a High Estimate of $0.63/share.

In case of Revenue Estimates, 19 analysts have provided their consensus Average Revenue Estimates for Abbott Laboratories as 7.47 Billion. According to these analysts, the Low Revenue Estimate for Abbott Laboratories is 7.44 Billion and the High Revenue Estimate is 7.53 Billion. The company had Year Ago Sales of 7.39 Billion.

These analysts also forecasted Growth Estimates for the Current Quarter for ABT to be 3.4%. They are projecting Next Quarter growth of 10.96%. For the next 5 years, Abbott Laboratories is expecting Growth of 12.44% per annum, whereas in the past 5 years the growth was 11.11% per annum.

Some buy side analysts are also providing their Analysis on Abbott Laboratories, where 5 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 1 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Abbott Laboratories might touch $86 high while the Average Price Target and Low price Target is $80.45 and $70 respectively.

Abbott Laboratories closed its last trading session at $78.62 with the gain of 0.46%. The Market Capitalization of the company stands at 139.03 Billion. The Company has 52-week high of $79.14 and 52-week low of $56.81. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 2.9% where SMA50 and SMA200 are 7.9% and 15.24% respectively. The Company Touched its 52-Week High on 03/13/19 and 52-Week Low on 05/03/18.

The Relative Volume of the company is 0.86 and Average Volume (3 months) is 6.62 million. The company’s P/E (price to earnings) ratio is 56.98 and Forward P/E ratio of 21.94.

The company shows its Return on Assets (ROA) value of 3.4%. The Return on Equity (ROE) value stands at 7.7%. While it’s Return on Investment (ROI) value is 6.1%.

While looking at the Stock’s Performance, Abbott Laboratories currently shows a Weekly Performance of 2.84%, where Monthly Performance is 5.22%, Quarterly performance is 9.94%, 6 Months performance is 18.59% and yearly performance percentage is 24.97%. Year to Date performance value (YTD perf) value is 9.19%. The Stock currently has a Weekly Volatility of 1.25% and Monthly Volatility of 1.28%.

Raytheon Company (RTN) will report its next earnings on Jan 31 BMO. The company reported the earnings of $2.93/Share in the last quarter where the estimated EPS by analysts was $2.89/share. The difference between the expected and actual EPS was $0.04/share, which represents an Earnings surprise of 1.4%.

Many analysts are providing their Estimated Earnings analysis for Raytheon Company and for the current quarter 18 analysts have projected that the stock could give an Average Earnings estimate of $2.5/share. These analysts have also projected a Low Estimate of $2.4/share and a High Estimate of $2.7/share.

In case of Revenue Estimates, 15 analysts have provided their consensus Average Revenue Estimates for Raytheon Company as 6.55 Billion. According to these analysts, the Low Revenue Estimate for Raytheon Company is 6.47 Billion and the High Revenue Estimate is 6.73 Billion. The company had Year Ago Sales of 6.27 Billion.

These analysts also forecasted Growth Estimates for the Current Quarter for RTN to be 13.6%. They are projecting Next Quarter growth of 15.51%. For the next 5 years, Raytheon Company is expecting Growth of 13.33% per annum, whereas in the past 5 years the growth was 9.24% per annum.

Some buy side analysts are also providing their Analysis on Raytheon Company, where 3 analysts have rated the stock as Strong buy, 1 analysts have given a Buy signal, 2 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Raytheon Company might touch $265 high while the Average Price Target and Low price Target is $207.89 and $175 respectively.

Raytheon Company closed its last trading session at $181.59 with the loss of -0.74%. The Market Capitalization of the company stands at 51.26 Billion. The Company has 52-week high of $229.75 and 52-week low of $144.27. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -1.84% where SMA50 and SMA200 are 4.52% and -3.58% respectively. The Company Touched its 52-Week High on 04/24/18 and 52-Week Low on 12/26/18.

The Relative Volume of the company is 0.54 and Average Volume (3 months) is 2.06 million. The company’s P/E (price to earnings) ratio is 17.76 and Forward P/E ratio of 13.67.

The company shows its Return on Assets (ROA) value of 9.4%. The Return on Equity (ROE) value stands at 26.7%. While it’s Return on Investment (ROI) value is 25.9%.

While looking at the Stock’s Performance, Raytheon Company currently shows a Weekly Performance of 0.02%, where Monthly Performance is -0.48%, Quarterly performance is 5.39%, 6 Months performance is -8.75% and yearly performance percentage is -14.42%. Year to Date performance value (YTD perf) value is 17.54%. The Stock currently has a Weekly Volatility of 1.57% and Monthly Volatility of 1.47%.

SHARE